subscribeSubscribe
Enforcement Report - Week of April 24, 2024

Enforcement Report - Week of April 24, 2024
FDA
24 Apr 2024
Share Share
Lilly`s Biologic Humalog (Insulin Lispro) Receives Approval in the U.S.

Lilly`s Biologic Humalog (Insulin Lispro) Receives Approval in the U.S.
FDA
21 Jul 2023
Share Share
Economists warn of costs if Medicare covers new obesity drugs

Economists warn of costs if Medicare covers new obesity drugs
REUTERS
11 Mar 2023
Share Share
Lilly to cut some US insulin prices by 70%, bolster cost cap

Lilly to cut some US insulin prices by 70%, bolster cost cap
CNBC
02 Mar 2023
Share Share
Eli Lilly`s Biologic Lyumjev (Insulin Lispro) Receives Approval in the U.S.

Eli Lilly`s Biologic Lyumjev (Insulin Lispro) Receives Approval in the U.S.
FDA
15 Oct 2022
Share Share
CivicaScript Announces Launch of its First Product

CivicaScript Announces Launch of its First Product
BUSINESSWIRE
03 Aug 2022
Share Share
Enforcement Report - Week of May 25, 2022

Enforcement Report - Week of May 25, 2022
FDA
25 May 2022
Share Share
As Lilly gears up for launches, existing meds post solid growth

As Lilly gears up for launches, existing meds post solid growth
Eric Sagonowsky FIERCEPHARMA
26 Oct 2021
Share Share
Eli Lilly ordered to pay royalties on blockbuster diabetes drugs

Eli Lilly ordered to pay royalties on blockbuster diabetes drugs
Max Gelman ENDPTS
22 Oct 2021
Share Share
Adocia’s partner Tonghua Dongbao Receives Clearance to Start BioChaperone®

Adocia’s partner Tonghua Dongbao Receives Clearance to Start BioChaperone®
GLOBENEWSWIRE
14 Oct 2021
Share Share